steephills

9 ms·

1. 1.▲
   by steephills 6y ago

   Pics or it didn't happen! We should not fall below wallstreetbets standards on HN.
2. 2.▲
   by steephills 6y ago

   Really? So you're saying, not all $10tn of quant funds in the US market are managed in the way you just described?
3. 3.▲
   by steephills 6y ago

   Yes, I just wanted to make a point: things that have names, that have a paper written about them, that have Wikipedia pages or even Nobel prices attached to them are in the same category. The market has priced them in decades ago. Thinking
4. 4.▲
   by steephills 6y ago

   Taking EPS as proxy for alpha is like trying to recognise banana pictures by looking at average yellow content: it is plausible, but roughly 100 years behind the other market participants. Don't do this kind of stuff with your hard ear
5. 5.▲
   by steephills 7y ago

   According to this article, the biggest R&D spenders in pharma are EU firms: https://www.evaluate.com/vantage/articles/data-insights/othe...